Abstract:Keloid is a disease in which fibroblasts abnormally proliferate and synthesize excessive amounts of extracellular matrix, including collagen and fibronectin, during the healing process of skin wounds, causing larger scars that exceed the boundaries of the original wound. Currently, surgical excision, cryotherapy, radiation, laser treatment, photodynamic therapy, pressure therapy, silicone gel sheeting, and pharmacotherapy are used alone or in combinations to treat this disease, but the outcomes are usually unsatisfactory. The purpose of this review is to examine whether natural products can help treat keloid disease. I introduce well-established therapeutic targets for this disease and various other emerging therapeutic targets that have been proposed based on the phenotypic difference between keloid-derived fibroblasts (KFs) and normal epidermal fibroblasts (NFs). We then present recent studies on the biological effects of various plant-derived extracts and compounds on KFs and NFs. Associated ex vivo, in vivo, and clinical studies are also presented. Finally, we discuss the mechanisms of action of the plant-derived extracts and compounds, the pros and cons, and the future tasks for natural product-based therapy for keloid disease, as compared with existing other therapies. Extracts of Astragalus membranaceus, Salvia miltiorrhiza, Aneilema keisak, Galla Chinensis, Lycium chinense, Physalis angulate, Allium sepa, and Camellia sinensis appear to modulate cell proliferation, migration, and/or extracellular matrix (ECM) production in KFs, supporting their therapeutic potential. Various phenolic compounds, terpenoids, alkaloids, and other plant-derived compounds could modulate different cell signaling pathways associated with the pathogenesis of keloids. For now, many studies are limited to in vitro experiments; additional research and development are needed to proceed to clinical trials. Many emerging therapeutic targets could accelerate the discovery of plant-derived substances for the prevention and treatment of keloid disease. I hope that this review will bridge past, present, and future research on this subject and provide insight into new therapeutic targets and pharmaceuticals, aiming for effective keloid treatment.

Research progress on targeted drugs and its applications in the treatment of keloids

Progress in Drug Treatment of Keloid

Comprehensive Insights into Keloid Pathogenesis and Advanced Therapeutic Strategies

Advances in the research of drug intralesional injection therapy in keloid

Pharmacological Treatment for Keloids.

Recent Advances in the Pathogenesis and Treatment of Keloid

Managing keloid scars: From radiation therapy to actual and potential drug deliveries

Established and Emerging Therapeutic Targets

Natural products - Dawn of keloid treatment

Progress of Intralesional Injections in the Treatment of Keloid

Epigenetic modification mechanisms involved in keloid: current status and prospect

Keloid management: a review of treatment modalities

[Research Advances on the Role and Mechanism of Inflammatory Response in the Formation of Hypertrophic Scars and Keloids].

Recent Developments in the Use of Intralesional Injections Keloid Treatment.

Keloids: a review of therapeutic management

Current potential therapeutic strategies targeting the TGF-β/Smad signaling pathway to attenuate keloid and hypertrophic scar formation

Research development in the pathogenic mechanism of keloids

Research advances on inflammatory responses involved in keloid development

[Research advances on pharmacological interventions for hypertrophic scar]

Novel needle‐type electrocoagulation and combination pharmacotherapy: Basic and clinical studies on efficacy and safety in treating keloids

Research Progress of Ginsenosides for the Prevention and Treatment of Pathological Scarring